Wikipedia

Chiral column chromatography

(Redirected from Chiral GC)

Chiral column chromatography[1][2] is a variant of column chromatography that is employed for the separation of chiral compounds, i.e. enantiomers, in mixtures such as racemates or related compounds. The chiral stationary phase (CSP) is made of a support, usually silica based, on which a chiral reagent or a macromolecule with numerous chiral centers is bonded or immobilized.[3]

The chiral stationary phase can be prepared by attaching a chiral compound to the surface of an achiral support such as silica gel. For example, one class of the most commonly used chiral stationary phases both in liquid chromatography and supercritical fluid chromatography is based on oligosaccharides[4] such as Amylose Cellulose or Cyclodextrin (in particular with β-cyclodextrin, a seven sugar ring molecule) immobilized on silica gel.

The principle can be also applied to the fabrication of Monolithic HPLC columns[5] or Gas Chromatography columns.[6] or Supercritical Fluid Chromatography columns.[7]

Principle of Chiral Column Chromatography

edit

The chiral stationary phase, CSP, can interact differently with two enantiomers, by a process known as chiral recognition. Chiral recognition depends on various interactions such as hydrogen bonding, π-π interaction, dipole stacking, inclusion complexation, steric, hydrophobic and electrostatic interaction, charge-transfer interactions, ionic interactions etc, between the analyte and the CSP, to form in-situ transient-diastereomeric complexes.

Most of the types of stationary phases can be classified as Pirkle type (Brush type),[8][9] Protein-based,[10] Cyclodextrins based,[11] Polymer-based carbohydrates (polysaccharide-based CSPs),[12] Macrocyclic antibiotic,[13] Chiral crown ethers,[14] imprinted polymers,[15] etc.

Brush type columns (Pirkle Type)

edit

The brush type, or Pirkle type chiral stationary phases[16][17] are also called π-π Donnor-Acceptor columns. According to some theoretical models separation on these CSPs is based on a three-point attachment between the solute and the bonded chiral ligand on the surface of the stationary phase. These interactions may be attractive or repulsive in nature, depending on the mutual properties. Pirkle columns discriminate enantiomers by binding of one enantiomer with the chiral stationary phase, thereby forming a diastereomeric complex through π-π bonding, hydrogen bonding, steric interactions, and/or dipole stacking. Pirkle CSP can be categorized into three classes:[18]

(i)                 π-electron acceptor

(ii)               π-electron donor

(iii)             π-electron donor-π-electron acceptor.

Protein-based chiral stationary phases

edit

A protein-based chiral stationary phase is based on silica-gel, on which a protein is immobilized or bonded.[19] The protein is based on many chiral centers, therefore the mechanism of chiral interaction between the protein and the analytes involves many interactions, such as hydrophobic and electrostatic interactions, hydrogen bonding and charge-transfer interactions, which may contribute to chiral recognition. Hydrophobic interactions between the protein and the analyte are affected by percent organic in the mobile phase. As the organic content increases, retention on protein-based columns decreases.

Polysaccharide chiral stationary phases

edit

The naturally occurring polysaccharide form the basis for an important group of columns designed for chiral separation. The main polysaccharides are cellulose, amylose, chitosan, dextran, xylan, curdlan, and inulin.[20] Polysaccharide-based stationary phase have a high loading capacity, many chiral centers and complicated stereochemistry, and can be used for the separation of a wide range of compounds.

Polysaccharide-based chiral stationary phases have a wide application due to their high separation efficiency, selectivity, sensitivity and reproducibility under normal and reversed-phase conditions, as well as their broad applicability for structurally diversified compounds.[21] The mechanism of chiral interaction on the polysaccharide-based chiral stationary phase has not yet been elucidated. However, the following interactions are believed to play a role in the retention:[22]

(i) Hydrogen bonding interactions of the polar chiral analyte with carbamate groups on the CSP;

(ii)  π-π interactions between phenyl groups on the CSP and aromatic groups of the solute;

(i) Dipole-dipole interactions

(ii) Steric interactions due to the helical structure of the CSP.

These effects on the retention process originate also from the functionality of the derivatives of the polysaccharide, its average molecular weight, and size distribution, the solvent used to immobilize it on the macroporous silica support, and the nature of the macroporous silica support itself.

Cyclodextrin (CD) chiral stationary phases

edit

Cyclodextrin (CD) chiral stationary phase is produced by partial degradation of starch by the enzyme cyclodextrin glycosyltransferase, followed by enzymatic coupling of the glucose units, forming a toroidal structure. CDs are cyclic oligosaccharides consisting of six (α CDs), seven (β CDs) and eight (γ CDs) glucopyranose units. The chiral recognition mechanism is based on a sort of inclusion complexation. Complexation involves the interaction of the hydrophobic portion of an analyte enantiomer with the non-polar interior of the cavity, while the polar functional groups can form a hydrogen bond with the polar hydroxyl chiral cavity space. The most important factor that determines whether the analyte molecule will fit into the cyclodextrin cavity is its size. The α-CD consists of 30 stereo-selective centers, β-CD consists of 35 stereo-selective centers and γ-CD consists of 40 stereo-selective centers. When the hydrophobic portion of the analyte is larger or smaller than the toroid's cavity size, inclusion will not occur.

Macrocyclic chiral stationary phases

edit

Macrocyclic chiral stationary phases consist of a silica support, on which macrocyclic antibiotic molecules are bonded.[13] The commonly used macrocyclic antibiotics include rifamycin, glycopeptides (for example, avoparcin, teicoplanin, ristocetin A, vancomycin, and their analogs), polypeptide antibiotic thiostrepton, and aminoglycosides (for example, fradiomycin, kanamycin, and streptomycin). The macrocyclic antibiotics interact with the analyte through hydrogen bonds, dipole-dipole interactions with the polar groups of the analyte, ionic interactions and π-π interactions.

Chiral crown ether

edit

Chiral crown stationary phases consist Crown ethers, immobilized or bonded to the support particles, are polyethers with a macrocyclic structure that can create host-guest complexes with alkali, earth-alkali metal ions, and ammonium cations. The skeleton of the cyclic structure is composed of oxygen and methylene groups arranged alternately. The electron-donating ether oxygens are positioned within the inner wall of the crown cavity, and are encircled by methylene groups in a collar-like arrangement. The chiral recognition is based on two distinct diastereomeric inclusion complexes that can be generated. The primary interactions facilitating complexation involve hydrogen bonds, formed between the three amine hydrogens and the oxygens of the macrocyclic ether, arranged in a tripod configuration. Additionally, ionic interactions, dipole-dipole interactions, or hydrogen bonds can occur between the carbocyclic groups and polar groups of the analytes, providing further support for the complexes.

Method Development

edit

Method development of chiral chromatography is still done by screening of columns from the various classes of chiral columns.[23] While chiral separation mechanisms are understandable in certain scenarios, and the retention characteristics of analytes within the chromatographic columns can occasionally be elucidated, the precise combination of chiral stationary phases (CSPs) and mobile-phase compositions that required to effectively resolve a specific enantiomeric pair often remains elusive.

The chemistry of CSP ligands significantly influences the creation of in-situ diastereomeric complexes upon the stationary phase surface. However, other method's conditions, such as mobile-phase solvents, their composition, mobile phase additives and column temperature can play equally critical roles. The final resolution of the enantiomers is the outcome of combination of intermolecular forces, and even a subtle change in them can determine the success or failure of separation. This complexity prevents from establishing routine method-development protocols that are universally applicable to a diverse range of enantiomers. In fact, sometimes the outcome of previous unsuccessful experiments do not provide any clue for the subsequent steps. Therefore, in practice, a chiral method development laboratory settings, acts like a high-throughput screening protocol,[24] of conducting a systematic screening of various CSP's by advanced column switching devices, trying automatically and systematically various mobile-phase combinations, effectively employing a trial-and-error strategy.[23]

Because of the highly complex retention mechanism of a chiral stationary-phase due to chiral recognition,[17] whose principles have not been deciphered, it is often difficult, if not impossible to predict in advance the steps that can be successfully applied to the enantiomers at hand as part of method development. That's why the standard approach in the method development is high throughput screening, to evaluate or examine a series of stationary phases, using various mobile-phase combinations, to increase the chance of finding a suitable separation condition.[23]

See also

edit

References

edit

  This article incorporates text by Celina Nazareth and Sanelly Pereira available under the CC BY 4.0 license.

  1. ^ Allenmark, Stig; Schurig, Volker (1997). "Chromatography on chiral stationary phases". Journal of Materials Chemistry. 7 (10): 1955–1963. doi:10.1039/A702403G. ISSN 1364-5501.
  2. ^ Teixeira, Joana; Tiritan, Maria Elizabeth; Pinto, Madalena M. M.; Fernandes, Carla (2019). "Chiral Stationary Phases for Liquid Chromatography: Recent Developments". Molecules. 24 (5): 865. doi:10.3390/molecules24050865. ISSN 1420-3049. PMC 6429359. PMID 30823495.
  3. ^ Nazareth, Celina; Pereira, Sanelly (2020). "A Review on Chiral Stationary Phases for Separation of Chiral Drugs" (PDF). International Journal of Pharmaceutical and Phytopharmacological Research. 10 (3): 77–91.
  4. ^ Yashima, Eiji (2001). "Polysaccharide-based chiral stationary phases for high-performance liquid chromatographic enantioseparation". Journal of Chromatography A. Chiral Separations. 906 (1): 105–125. doi:10.1016/S0021-9673(00)00501-X. ISSN 0021-9673. PMID 11215883.
  5. ^ Yingjie Li; Chunhui Song; Lingyi Zhang; Weibing Zhang; Honggang Fu (January 2010). "Fabrication and evaluation of chiral monolithic column modified by β-cyclodextrin derivatives". Talanta. 80 (3): 1378–1384. doi:10.1016/j.talanta.2009.09.039. PMID 20006102.
  6. ^ Yi-Ming Liu; Patricia Gordon; Shelby Green; Jonathan V. Sweedler (September 2000). "Determination of salsolinol enantiomers by gas chromatography-mass spectrometry with cyclodextrin chiral columns". Analytica Chimica Acta. 420 (1): 81–88. doi:10.1016/S0003-2670(00)00986-7.
  7. ^ West, Caroline (2019). "Recent trends in chiral supercritical fluid chromatography". TrAC Trends in Analytical Chemistry. 120: 115648. doi:10.1016/j.trac.2019.115648. ISSN 0165-9936. S2CID 202884037.
  8. ^ Fernandes, Carla; Tiritan, Maria Elizabeth; Pinto, Madalena (2013). "Small Molecules as Chromatographic Tools for HPLC Enantiomeric Resolution: Pirkle-Type Chiral Stationary Phases Evolution". Chromatographia. 76 (15): 871–897. doi:10.1007/s10337-013-2469-8. ISSN 1612-1112. S2CID 97668558.
  9. ^ Tiritan, Maria Elizabeth; Pinto, Madalena; Fernandes, Carla (2023-04-12), Cass, Quezia Bezerra; Tiritan, Maria Elizabeth; Junior, João Marcos Batista; Barreiro, Juliana Cristina (eds.), "Pirkle Type", Chiral Separations and Stereochemical Elucidation (1 ed.), Wiley, pp. 325–362, doi:10.1002/9781119802280.ch9, ISBN 978-1-119-80225-9, retrieved 2023-10-15
  10. ^ Haginaka, Jun (2001). "Protein-based chiral stationary phases for high-performance liquid chromatography enantioseparations". Journal of Chromatography A. Chiral Separations. 906 (1): 253–273. doi:10.1016/S0021-9673(00)00504-5. ISSN 0021-9673. PMID 11215891.
  11. ^ Xiao, Yin; Ng, Siu-Choon; Tan, Timothy Thatt Yang; Wang, Yong (2012). "Recent development of cyclodextrin chiral stationary phases and their applications in chromatography". Journal of Chromatography A. Chiral Separations and Enantioselectivity. 1269: 52–68. doi:10.1016/j.chroma.2012.08.049. ISSN 0021-9673. PMID 22959844.
  12. ^ Geryk, Radim; Kalíková, Květa; Vozka, Jiří; Plecitá, Denisa; Schmid, Martin G.; Tesařová, Eva (2014-10-10). "Enantioselective potential of chiral stationary phases based on immobilized polysaccharides in reversed phase mode". Journal of Chromatography A. Enantioseparations - 2014. 1363: 155–161. doi:10.1016/j.chroma.2014.06.040. ISSN 0021-9673. PMID 24997511.
  13. ^ a b Armstrong, Daniel W.; Tang, Yubing.; Chen, Shushi.; Zhou, Yiwen.; Bagwill, Christina.; Chen, Jing-Ran. (1994). "Macrocyclic Antibiotics as a New Class of Chiral Selectors for Liquid Chromatography". Analytical Chemistry. 66 (9): 1473–1484. doi:10.1021/ac00081a019. ISSN 0003-2700.
  14. ^ Li, Yanzhe; Sheng, Zhe; Zhu, Chuanlei; Yin, Wei; Chu, Changhu (2018). "Silica based click-dibenzo-18-crown-6-ether high performance liquid chromatography stationary phase and its application in separation of fullerenes". Talanta. 178: 195–201. doi:10.1016/j.talanta.2017.07.037. ISSN 0039-9140. PMID 29136812.
  15. ^ Pu, Junli; Wang, Hongwei; Huang, Chao; Bo, Chunmiao; Gong, Bolin; Ou, Junjie (2022). "Progress of molecular imprinting technique for enantioseparation of chiral drugs in recent ten years". Journal of Chromatography A. 1668: 462914. doi:10.1016/j.chroma.2022.462914. ISSN 0021-9673. PMID 35220013. S2CID 246980680.
  16. ^ Fernandes, Carla; Tiritan, Maria Elizabeth; Pinto, Madalena (2013-08-01). "Small Molecules as Chromatographic Tools for HPLC Enantiomeric Resolution: Pirkle-Type Chiral Stationary Phases Evolution". Chromatographia. 76 (15): 871–897. doi:10.1007/s10337-013-2469-8. ISSN 1612-1112. S2CID 97668558.
  17. ^ a b Magora, Amir; Abu-Lafi, Saleh; Levin, Shulamit (2000). "Comparison of the enantioseparation of racemic uridine analogs on Whelk-O 1 and ChiralPak-AD columns". Journal of Chromatography A. 866 (2): 183–194. doi:10.1016/S0021-9673(99)01108-5. ISSN 0021-9673. PMID 10670808.
  18. ^ Fernandes, Carla; Phyo, Ye’ Zaw; Silva, Ana Sofia; Tiritan, Maria Elizabeth; Kijjoa, Anake; Pinto, Madalena M.M. (2018-04-03). "Chiral Stationary Phases Based on Small Molecules: An Update of the Last 17 Years". Separation & Purification Reviews. 47 (2): 89–123. doi:10.1080/15422119.2017.1326939. ISSN 1542-2119. S2CID 99405457.
  19. ^ Zhu, Bolin; Xue, Mengyao; Liu, Beibei; Li, Qing; Guo, Xingjie (2019). "Enantioselective separation of eight antihistamines with α1-acid glycoprotein-based chiral stationary phase by HPLC: Development and validation for the enantiomeric quality control". Journal of Pharmaceutical and Biomedical Analysis. 176: 112803. doi:10.1016/j.jpba.2019.112803. ISSN 0731-7085. PMID 31442761. S2CID 201630751.
  20. ^ Aboul-Enein, Hassan Y (2001). "High-performance liquid chromatographic enantioseparation of drugs containing multiple chiral centers on polysaccharide-type chiral stationary phases". Journal of Chromatography A. Chiral Separations. 906 (1): 185–193. doi:10.1016/S0021-9673(00)00950-X. ISSN 0021-9673. PMID 11215887.
  21. ^ Nie, Y.; Liu, X.; Yang, X.; Zhao, Z. (2013). "Review: Recent Application of Chiral Liquid Chromatography-Tandem Mass Spectrometric Methods for Enantiomeric Pharmaceutical and Biomedical Determinations". Journal of Chromatographic Science. 51 (8): 753–763. doi:10.1093/chromsci/bms209. ISSN 0021-9665. PMID 23315149.
  22. ^ Zhao, Binwu; Oroskar, Priyanka A.; Wang, Xiaoyu; House, David; Oroskar, Anil; Oroskar, Asha; Jameson, Cynthia; Murad, Sohail (2017). "The Composition of the Mobile Phase Affects the Dynamic Chiral Recognition of Drug Molecules by the Chiral Stationary Phase". Langmuir. 33 (42): 11246–11256. doi:10.1021/acs.langmuir.7b02337. ISSN 0743-7463. PMID 28826215.
  23. ^ a b c Tarafder, Abhijit; Miller, Larry (2021). "Chiral chromatography method screening strategies: Past, present and future". Journal of Chromatography A. 1638: 461878. doi:10.1016/j.chroma.2021.461878. ISSN 0021-9673. PMID 33477025. S2CID 231677607.
  24. ^ Lin, Jessica; Tsang, Charlotte; Lieu, Raymond; Zhang, Kelly (2020). "Method screening strategies of stereoisomers of compounds with multiple chiral centers and a single chiral center". Journal of Chromatography A. 1624: 461244. doi:10.1016/j.chroma.2020.461244. ISSN 0021-9673. PMID 32540081. S2CID 219700768.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Chiral_column_chromatography&oldid=1212903362"